Quick Heal Technologies Ltd

Quick Heal Technologies has allotted 18,015 equity shares under ESOP on 27 February 2026. Powered by Capital Market - Live

Quick Heal Technologies has allotted 153 equity shares under ESOP on 30 January 2026. With this allotment, the paid up equity share capital has increased to Rs 54,21,50,750/- divided into 5,42,15,075 Nos. of Equity Share of Rs 10/- each. Powered by Capital Market - Live

Quick Heal Technologies will hold a meeting of the Board of Directors of the Company on 29 January 2026.Powered by Capital Market - Live

Quick Heal Technologies has allotted 15,352 equity shares under ESOP on 24 December 2025. Powered by Capital Market - Live

The company said the engagement is aligned with its ongoing cybersecurity business and supports its strategic objective of delivering comprehensive security solutions to customers. The scope and value of the project mark a key milestone in Quick Heal's continued collaboration with government institutions. According to the company's exchange filing, the contract is valid for five years. Quick Heal also clarified that neither its promoters nor the promoter group has any interest in the awarding authority, and the deal does not fall under related-party transactions as per regulatory guidelines. Quick Heal Technologies is a global cybersecurity solutions provider. It offers end-to-end cybersecurity solutions across B2C, B2B, and B2G segments. Through its flagship brands, Quick Heal and Seqrite, the company delivers AI-powered, patented technologies that safeguard endpoints, networks, data, mobile devices, and cloud environments. The company's consolidated net profit soared 90.6% to Rs 7.91 crore on 13.65% jump in revenue from operations to Rs 83.52 crore in Q2 FY26 over Q2 FY25. Powered by Capital Market - Live

The company said the engagement is aligned with its ongoing cyber security business and supports its strategic objective of delivering comprehensive security solutions to customers. The scope and value of the project mark a key milestone in Quick Heal's continued collaboration with government institutions. According to the company's exchange filing, the contract is valid for five years. Quick Heal also clarified that neither its promoters nor the promoter group has any interest in the awarding authority, and the deal does not fall under related-party transactions as per regulatory guidelines. Quick Heal Technologies is a global cybersecurity solutions provider. It offers end-to-end cybersecurity solutions across B2C, B2B, and B2G segments. Through its flagship brands, Quick Heal and Seqrite, the company delivers AI-powered, patented technologies that safeguard endpoints, networks, data, mobile devices, and cloud environments. The company's consolidated net profit soared 90.6% to Rs 7.91 crore on a 13.65% jump in revenue from operations to Rs 83.52 crore in Q2 FY26 over Q2 FY25. The counter rose 1.82% to settle at Rs 307.50 on the BSE. Powered by Capital Market - Live

Quick Heal Technologies announced that Ajit Zanjad, Vice President Head of Delivery of the Company, has tendered his resignation from the services of the Company for professional growth, with effect from 28 November 2025. Powered by Capital Market - Live

Quick Heal Technologies has entered into contract with NFSU Research and Innovation Council (NFSU-RIC) (NFSU is an Institution of National Importance under Ministry of Home Affairs), for implementation of the integrated cyber security solutions. The contract valued at Rs 64.25 crore is valid for a period of five years. Powered by Capital Market - Live

Quick Heal Technologies has allotted 9,103 equity shares under ESOP on 27 November 2025. With this allotment, the paid up equity share capital has increased to Rs 54,19,95,700/- divided into 5,41,99,570 nos. of equity share of Rs 10/- each. Powered by Capital Market - Live

Profit before tax (PBT) surged 102.76% to Rs 10.28 crore in Q2 FY26, compared with Rs 5.07 crore in Q2 FY25. EBITDA stood at Rs 9.2 crore in Q2 FY26, registering the growth of 196.77% compared with Rs 3.1 crore in Q2 FY25. EBITDA margin stood at 11.1% in Q2 FY26 as against 4.2% in Q2 FY25. Kailash Katkar, chairman and managing director of Quick Heal Technologies, commented, 'Q2 FY26 witnessed good performance across both verticals of our business, which is a clear reflection of the resilience and diversification of our cybersecurity portfolio through continued investments in differentiated, AI-led innovations. The consumer business has shown recovery with seasonal tailwinds, while our enterprise vertical continues to gain momentum through innovative solution offerings. This balanced growth across our dual business streams reinforces our commitment to delivering comprehensive cybersecurity solutions that address evolving market needs and positions us well for sustained growth in the future.' Ankit Maheshwari, chief financial officer, Quick Heal Technologies, added, 'We are pleased with the revenue growth momentum this quarter. Owing to the stable cost structures, the revenue improvement enabled us to restore healthy margins. Our continued investments in R&D and S&M for market expansion are key tenets for our long-term pivot and have started to show positive traction. We are geared up for the second half of the year for continued shareholder value creation.' Quick Heal Technologies is a global cybersecurity solutions provider. It offers end-to-end cybersecurity solutions across B2C, B2B, and B2G segments. Through its flagship brands, Quick Heal and Seqrite, the company delivers AI-powered, patented technologies that safeguard endpoints, networks, data, mobile devices, and cloud environments.Powered by Capital Market - Live